The company aims to advise businesses in the life sciences sector, particularly in the fields of oncology, hematology, as well as immunology and inflammatory diseases (I&I). This includes strategic and operational support for drug development, regulatory affairs, the design of clinical studies, and the conduct of due diligence investigations for investors and companies. The company may establish branches and subsidiaries both domestically and abroad, and may participate in other companies both domestically and abroad, as well as conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, dispose of, and manage real property both domestically and abroad. It may also arrange financing for its own or third-party account, as well as provide security for the liabilities of affiliated companies.